United Services Automobile Association’s PDL BioPharma, Inc. PDLI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q3
Sell
-86,296
Closed -$271K 2189
2019
Q2
$271K Buy
86,296
+5,273
+7% +$17.1K ﹤0.01% 1919
2019
Q1
$301K Sell
81,023
-8,553
-10% -$28.9K ﹤0.01% 1898
2018
Q4
$260K Buy
89,576
+10,354
+13% +$28.4K ﹤0.01% 1889
2018
Q3
$208K Buy
79,222
+11,010
+16% +$27K ﹤0.01% 2136
2018
Q2
$160K Buy
68,212
+21,899
+47% +$61.1K ﹤0.01% 2169
2018
Q1
$136K Buy
46,313
+33,002
+248% +$90.1K ﹤0.01% 2144
2017
Q4
$36K Buy
+13,311
New +$40.9K ﹤0.01% 1456

Other funds holding PDLI

United Services Automobile Association's PDLI Position: Q3 2019 in Review

United Services Automobile Association sold out of PDL BioPharma, Inc. (PDLI) in Q3 2019, closing a stake of 86,296 shares — an estimated $271K sold.

United Services Automobile Association first reported a position in PDLI in Q4 2017 and held it in 7 quarters. The position peaked at $301K in Q1 2019. 140 funds tracked by Wall St. Rank hold PDLI as of Q3 2019.

  • United Services Automobile Association reported no remaining PDL BioPharma, Inc. position as of Q3 2019 after selling out during the quarter.
  • United Services Automobile Association sold 86,296 PDL BioPharma, Inc. shares in Q3 2019, an estimated $271K.
  • United Services Automobile Association first reported a position in PDL BioPharma, Inc. in Q4 2017 and held it in 7 quarters.
  • United Services Automobile Association's PDL BioPharma, Inc. position peaked at $301K in Q1 2019.
  • 140 funds tracked by Wall St. Rank held PDL BioPharma, Inc. as of Q3 2019.

Based on United Services Automobile Association's 13F filing for Q3 2019, filed 13 Nov 2019.